Capital Flow Monitor · Sponsors · CIK 1773773
ABK Biomedical Inc
155 CHAIN LAKE DRIVE, UNIT 32, HALIFAX, A5, B3S 1B3 · 902-442-4009
Other · Corporation· inc. NOVA SCOTIA, CANADA true
Fit score
—
Offering
$2.6M
Sold
$2.6M
% sold
100.0%
Investors
6
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-11-03 | D ·current | 506(b) | $2.6M | $2.6M | 100.0% | 6 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Michael Mangano — Executive Officer / Director, Halifax, A5
- Gary Donofrio — Executive Officer, Halifax, A5
- Mike Tyson — Executive Officer, Halifax, A5
- Aravind Arepally — Executive Officer, Halifax, A5
- Marc Gregoire — Executive Officer, Halifax, A5
- David Dobrowsky — Executive Officer, Halifax, A5
- Anthony Headley — Executive Officer, Halifax, A5
-
Aaron Berez — Director, Halifax, A5
1 other raise
- Analytics for Life Inc. $550K of $15.0M · 3.7%
- Keten Patel — Director, Halifax, A5
- Carissa Bellardine Black — Director, Halifax, A5
-
James Eadie — Director, Halifax, A5
1 other raise
- CryOSA, Inc. $6.0M of $15.0M · 39.9%
-
Joseph Siletto — Director, Halifax, A5
2 other raises
- 270 Healthcare Growth Fund I LP $113.9M of —
- 270 Healthcare Growth Fund I (LUX) SCSp-RAIF $113.9M of —
-
James McLaren — Director, Halifax, A5
1 other raise
- Analytics for Life Inc. $550K of $15.0M · 3.7%
- Lucy Bataneant — Executive Officer, Halifax, A5
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.